データなし
データなし
Legalizing Psychedelics: Is Massachusetts Next?
FDA Is Said to See "Path Forward" for Ecstasy-based Drug
Bright Minds Rally Ends as Psychedelic Stocks Extend Volatility
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating...
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
データなし
データなし